Addressing medicines shortages in the European Union

Future MEPs: take control to ensure access to medicines

Civil society letter calls for European Parliament to support global access to medical tools

Enabling Access to Medical Innovations for all


Flexibilities Navigator: An evermore valuable resource

Lack of diagnostics helps fuel AMR


Make good on access to medicine commitments HAI asks new Dutch Health Minister

Call for medical journals to support clinical trial transparency


Transparency: Bringing the Issue to Life

Working with the European Parliament

Talking Medicine Pricing

European Commission’s State of the Union address: Reflection and Transparency Notable Absences

Clinical Trial Data and the Risk of Bias

Getting Hack to Reality

C-TAP has not (yet) lived up to high expectations

A Pandemic Response Lacking Moral Leadership

MPs and MEPs Call for TRIPS Waiver

Challenging the IP Protection Framework

5 reasons to support the European Citizens’ Initiative No Profit On Pandemic

5 redenen om het Europees burgerinitiatief No Profit on Pandemic te steunen

Access to Medicines in Europe

The WHO Executive Board (EB148) in 2021


Access to medicines in the EU in 2020

There is no UHC without Universal Medicines Coverage

HAI’s Great Health Hack Delivers Great Ideas for Access to Meds

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

HAI Releases Annual Report 2019

Why TRIPS flexibilities are a crucial mechanism for access to medicines